- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 128,450 | 11.07.24 20:52:58 | +1,150 | +0,90% | 128,420 | 128,440 | 127,610 | 127,300 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 97,000 | 11.07.24 20:48:30 | +0,700 | +0,73% | 96,750 | 97,200 | 97,300 | 96,300 |
